Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
Article in Frontiers in Endocrinology (July 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Frontiers in Endocrinology (July 2023)